癌基因诱导的衰老：癌症的双刃剑。
Oncogene-induced senescence: a double edged sword in cancer.
机构信息
Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
出版信息
Acta Pharmacol Sin. 2018 Oct;39(10):1553-1558. doi: 10.1038/aps.2017.198. Epub 2018 Apr 5.
Abstract
Oncogene-induced cellular senescence (OIS) is a complex program that is triggered in response to aberrant activation of oncogenic signaling. Initially, OIS was thought to be a barrier to malignant transformation because of its suppression on cell proliferation. Later studies showed that senescence induced by oncogenes can also promote the initiation and development of cancer. The opposing effects of OIS occur through different combinations of downstream effectors as well as the interplay of senescent cells and the microenvironment, such as senescence-associated inflammation. Here, we review the common features and molecular mechanisms underlying OIS and the interaction between senescent cells and the microenvironment. We propose that targeting senescent cells may have a beneficial therapeutic effect during the treatment of cancer.
摘要
癌基因诱导的细胞衰老（OIS）是一种复杂的程序，它是对致癌信号异常激活的反应而被触发的。最初，由于其对细胞增殖的抑制作用，OIS 被认为是恶性转化的障碍。后来的研究表明，癌基因诱导的衰老也可以促进癌症的发生和发展。OIS 的相反作用是通过不同的下游效应子组合以及衰老细胞与微环境（如衰老相关炎症）的相互作用来实现的。在这里，我们回顾了 OIS 的共同特征和分子机制，以及衰老细胞与微环境之间的相互作用。我们提出，针对衰老细胞可能在癌症治疗中有有益的治疗效果。
相似文献
1
Oncogene-induced senescence: a double edged sword in cancer.癌基因诱导的衰老：癌症的双刃剑。
Acta Pharmacol Sin. 2018 Oct;39(10):1553-1558. doi: 10.1038/aps.2017.198. Epub 2018 Apr 5.
2
Regulation of senescence and the SASP by the transcription factor C/EBPβ.转录因子 C/EBPβ对衰老和 SASP 的调控。
Exp Gerontol. 2019 Dec;128:110752. doi: 10.1016/j.exger.2019.110752. Epub 2019 Oct 22.
3
Coordinated post-transcriptional control of oncogene-induced senescence by UNR/CSDE1.UNR/CSDE1 协调转录后调控癌基因诱导的衰老。
Cell Rep. 2022 Jan 11;38(2):110211. doi: 10.1016/j.celrep.2021.110211.
4
Nucleotide metabolism, oncogene-induced senescence and cancer.核苷酸代谢、癌基因诱导的衰老与癌症
Cancer Lett. 2015 Jan 28;356(2 Pt A):204-10. doi: 10.1016/j.canlet.2014.01.017. Epub 2014 Jan 29.
5
Oncogene-induced senescence pathways weave an intricate tapestry.癌基因诱导的衰老途径构成了一幅错综复杂的图景。
Cell. 2007 Jan 26;128(2):233-4. doi: 10.1016/j.cell.2007.01.005.
6
Oncogene-induced senescence: From biology to therapy.癌基因诱导的衰老：从生物学到治疗。
Mech Ageing Dev. 2020 Apr;187:111229. doi: 10.1016/j.mad.2020.111229. Epub 2020 Mar 18.
7
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.线粒体门控丙酮酸脱氢酶在癌基因诱导衰老中的关键作用。
Nature. 2013 Jun 6;498(7452):109-12. doi: 10.1038/nature12154. Epub 2013 May 19.
8
Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes.在人类浸润性乳腺癌中检测细胞衰老可区分不同的乳腺肿瘤亚型。
Oncotarget. 2016 Nov 15;7(46):74846-74859. doi: 10.18632/oncotarget.12432.
9
The Immortal Senescence.不朽的衰老。
Methods Mol Biol. 2017;1534:1-15. doi: 10.1007/978-1-4939-6670-7_1.
10
Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation.蛋白激酶D1通过调节衰老相关炎症，对Ras诱导的衰老和肿瘤抑制至关重要。
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7683-8. doi: 10.1073/pnas.1310972111. Epub 2014 May 14.
引用本文的文献
1
Interrogating the regulatory epigenome of cellular senescence.探究细胞衰老的调控表观基因组。
Cell Mol Life Sci. 2025 Aug 31;82(1):328. doi: 10.1007/s00018-025-05848-w.
2
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons.氧化应激驱动的细胞衰老：机制串扰与治疗前景
Antioxidants (Basel). 2025 Aug 12;14(8):987. doi: 10.3390/antiox14080987.
3
Targeting Senescence in Oncology: An Emerging Therapeutic Avenue for Cancer.肿瘤学中的衰老靶向治疗：癌症治疗的新兴途径
Curr Oncol. 2025 Aug 18;32(8):467. doi: 10.3390/curroncol32080467.
4
The Role of Senescence, its Therapeutic Relevance and Clinical Implications in the Tumor Microenvironment.衰老在肿瘤微环境中的作用、其治疗相关性及临床意义
Theranostics. 2025 Jul 28;15(16):8675-8703. doi: 10.7150/thno.112633. eCollection 2025.
5
Hallmarks and mechanisms of cellular senescence in aging and disease.衰老和疾病中细胞衰老的特征与机制
Cell Death Discov. 2025 Aug 4;11(1):364. doi: 10.1038/s41420-025-02655-x.
6
Mutations in tumor signaling, metastases, and synthetic lethality establish distinct patterns.肿瘤信号传导、转移和合成致死性方面的突变呈现出不同的模式。
PLoS Comput Biol. 2025 Aug 4;21(8):e1013351. doi: 10.1371/journal.pcbi.1013351. eCollection 2025 Aug.
7
The Inositol-5-Phosphatase SHIP1: Expression, Regulation and Role in Acute Lymphoblastic Leukemia.肌醇-5-磷酸酶SHIP1：在急性淋巴细胞白血病中的表达、调控及作用
Int J Mol Sci. 2025 Jul 19;26(14):6935. doi: 10.3390/ijms26146935.
8
Molecular Regulation of SASP in Cellular Senescence: Therapeutic Implications and Translational Challenges.细胞衰老过程中衰老相关分泌表型（SASP）的分子调控：治疗意义与转化挑战
Cells. 2025 Jun 20;14(13):942. doi: 10.3390/cells14130942.
9
Hallmarks of cellular senescence: biology, mechanisms, regulations.细胞衰老的特征：生物学、机制与调控
Exp Mol Med. 2025 Jul 10. doi: 10.1038/s12276-025-01480-7.
10
Future Perspectives in Senescence-Based Therapies for Head and Neck Cancer.头颈部癌基于衰老的治疗的未来展望
Cancers (Basel). 2025 Jun 12;17(12):1965. doi: 10.3390/cancers17121965.
本文引用的文献
1
Identification of senescent cell surface targetable protein DPP4.衰老细胞表面可靶向蛋白DPP4的鉴定
Genes Dev. 2017 Aug 1;31(15):1529-1534. doi: 10.1101/gad.302570.117. Epub 2017 Sep 6.
2
SASP: Tumor Suppressor or Promoter? Yes!柳氮磺胺吡啶：肿瘤抑制因子还是促进因子？答案是！两者皆是！
Trends Cancer. 2016 Nov;2(11):676-687. doi: 10.1016/j.trecan.2016.10.001. Epub 2016 Oct 24.
3
Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases.衰老相关分泌表型的影响及其作为衰老相关疾病治疗靶点的潜力。
Cancer Sci. 2017 Apr;108(4):563-569. doi: 10.1111/cas.13184. Epub 2017 Apr 18.
4
The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.衰老相关分泌表型诱导细胞可塑性和组织再生。
Genes Dev. 2017 Jan 15;31(2):172-183. doi: 10.1101/gad.290635.116. Epub 2017 Jan 31.
5
Therapeutic interventions for aging: the case of cellular senescence.衰老的治疗干预措施：以细胞衰老为例。
Drug Discov Today. 2017 May;22(5):786-795. doi: 10.1016/j.drudis.2017.01.004. Epub 2017 Jan 19.
6
WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation.WSB1通过靶向降解ATM来克服癌基因诱导的衰老。
Cell Res. 2017 Feb;27(2):274-293. doi: 10.1038/cr.2016.148. Epub 2016 Dec 13.
7
The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence.p53蛋白对细胞功能的调控：细胞衰老
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a026112. doi: 10.1101/cshperspect.a026112.
8
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression.衰老相关免疫反应在肝脏肿瘤监测与肿瘤进展中的不同功能
Cancer Cell. 2016 Oct 10;30(4):533-547. doi: 10.1016/j.ccell.2016.09.003.
9
The cell fate: senescence or quiescence.细胞命运：衰老还是静止。
Mol Biol Rep. 2016 Nov;43(11):1213-1220. doi: 10.1007/s11033-016-4065-0. Epub 2016 Aug 24.
10
RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis.RelA在小鼠Kras驱动的胰腺癌发生过程中调节CXCL1/CXCR2依赖性癌基因诱导的衰老。
J Clin Invest. 2016 Aug 1;126(8):2919-32. doi: 10.1172/JCI86477. Epub 2016 Jul 25.
Zotero 插件